Literature DB >> 3410886

Tissue-specific analogues of erythrocyte protein 4.1 retain functional domains.

R A Anderson1, I Correas, C Mazzucco, J D Castle, V T Marchesi.   

Abstract

Analogues of the human erythroid membrane skeletal component protein 4.1 have been identified in perfused rat tissues and human T and B lymphocyte cell lines. olyclonal antibodies were used which are specific for all domains of protein 4.1, the spectrin-actin-promoting 8-Kd peptide, the membrane-binding 30-Kd domain, and the 50-Kd domain. Antibody reactivity, by Western blotting of tissue homogenates, shows reactivity with proteins varying in molecular weight from 175 Kd to 30 Kd. Further, these protein 4.1 analogues appear to be expressed in a tissue-specific fashion. Of the analogues detected there appear to be at least three classes: analogues containing all erythroid protein 4.1 domains, analogues containing all domains but with modified antigenic epitopes, and analogues containing only some domains. Chemical cleavage at cysteine linkages indicates that in analogues containing the 30-Kd region the location of cysteine is highly conserved. This datum suggests that in nonerythroid 4.1 isoforms of higher molecular weight the additional protein mass is added to the amino terminal end (30 Kd end).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3410886     DOI: 10.1002/jcb.240370303

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  19 in total

1.  A novel neuron-enriched homolog of the erythrocyte membrane cytoskeletal protein 4.1.

Authors:  L D Walensky; S Blackshaw; D Liao; C C Watkins; H U Weier; M Parra; R L Huganir; J G Conboy; N Mohandas; S H Snyder
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  The N-terminal 209-aa domain of high molecular-weight 4.1R isoforms abrogates 4.1R targeting to the nucleus.

Authors:  C M Luque; M J Lallena; C M Pérez-Ferreiro; Y de Isidro; G De Cárcer; M A Alonso; I Correas
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  A nonerythroid isoform of protein 4.1R interacts with components of the contractile apparatus in skeletal myofibers.

Authors:  A Kontrogianni-Konstantopoulos; S C Huang; E J Benz
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

4.  Deciphering the nuclear import pathway for the cytoskeletal red cell protein 4.1R.

Authors:  P Gascard; W Nunomura; G Lee; L D Walensky; S W Krauss; Y Takakuwa; J A Chasis; N Mohandas; J G Conboy
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

5.  Inhibition of protein 4.1 R and NuMA interaction by mutagenization of their binding-sites abrogates nuclear localization of 4.1 R.

Authors:  Subhendra N Mattagajasingh; Shu-Ching Huang; Edward J Benz
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

6.  Protein 4.1R self-association: identification of the binding domain.

Authors:  Carmen M Pérez-Ferreiro; Eva Lospitao; Isabel Correas
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

7.  Phosphorylation of protein 4.1 on tyrosine-418 modulates its function in vitro.

Authors:  G Subrahmanyam; P J Bertics; R A Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

8.  Structural protein 4.1 is located in mammalian centrosomes.

Authors:  S W Krauss; J A Chasis; C Rogers; N Mohandas; G Krockmalnic; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 9.  Role of tissue specific alternative pre-mRNA splicing in the differentiation of the erythrocyte membrane.

Authors:  E J Benz; S C Huang
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

10.  Localization of immuno-analogues of erythrocyte protein 4.1 and spectrin in epidermis of psoriasis vulgaris.

Authors:  T Shimizu; Y Takakuwa; H Koizumi; T Ishibashi; A Ohkawara
Journal:  Histochem Cell Biol       Date:  1995-05       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.